Nagano Hiroaki, Muraoka Mitsue, Takagi Koichiro
Department of Obstetrics and Gynecology, Tokyo Women's Medical University, Medical Center East, 2-1-10 Nishiogu, Arakawa-ku, Tokyo 116-8567, Japan.
Department of Obstetrics and Gynecology, Tokyo Women's Medical University, Medical Center East, 2-1-10 Nishiogu, Arakawa-ku, Tokyo 116-8567, Japan.
Int J Surg Case Rep. 2014;5(7):412-5. doi: 10.1016/j.ijscr.2014.04.017. Epub 2014 Apr 18.
Occasionally, lymph node metastases represent the only component at the time of recurrence of ovarian cancer. Here we report the case of a 78-year-old Japanese female who underwent successful surgery for recurrent ovarian cancer with multiple lymph node metastases.
The patient was referred to our institution with recurrent disease accompanied by chemoresistant multiple retroperitoneal lymph node metastases five years after the initial therapy for stage IIIc serous adenocarcinoma of the ovary. Positron emission tomography/computed tomography (PET/CT) revealed the involvement of two para-aortic nodes and two pelvic nodes, with no other positive site. The patient underwent systematic para-aortic and pelvic lymphadenectomy, and the metastatic nodes were completely resected. Histopathological examination revealed metastatic high-grade adenocarcinoma in four of 63 dissected lymph node specimens. The patient has been in clinical remission for over four years without any further additional therapies.
In our case, the metastatic nodes predicted by PET/CT completely corresponded to the actual metastatic nodes; however, PET/CT often fails to identify microscopic disease in pathological positive nodes. We cannot reliably predict whether lymph node metastasis will persist in the limited range. Therefore, systematic lymphadenectomy with therapeutic intent should be performed, although it does not always mean that we remove all cancer cells.
The findings from this case suggest that, even if used as secondary cytoreductive surgery in the context of a recurrent disease, systematic aortic and pelvic node dissection might sometimes contribute to the control if not cure of ovarian cancer.
偶尔,淋巴结转移是卵巢癌复发时的唯一表现。在此,我们报告一例78岁日本女性患者,她因复发性卵巢癌伴多发淋巴结转移接受了成功的手术治疗。
该患者在初次治疗IIIc期卵巢浆液性腺癌五年后,因复发性疾病伴化疗耐药的多发腹膜后淋巴结转移被转诊至我院。正电子发射断层扫描/计算机断层扫描(PET/CT)显示腹主动脉旁两个淋巴结和盆腔两个淋巴结受累,无其他阳性部位。患者接受了系统性腹主动脉旁和盆腔淋巴结清扫术,转移淋巴结被完全切除。组织病理学检查显示,在63个切除的淋巴结标本中,有4个存在转移性高级别腺癌。患者已临床缓解超过四年,未接受任何进一步的额外治疗。
在我们的病例中,PET/CT预测的转移淋巴结与实际转移淋巴结完全相符;然而,PET/CT常常无法识别病理阳性淋巴结中的微小病灶。我们无法可靠地预测淋巴结转移是否会局限于有限范围内持续存在。因此,应进行具有治疗目的的系统性淋巴结清扫术,尽管这并不总是意味着我们能清除所有癌细胞。
该病例的结果表明,即使在复发性疾病中作为二次减瘤手术使用,系统性腹主动脉旁和盆腔淋巴结清扫术有时可能有助于控制(即使不能治愈)卵巢癌。